https://de.marketscreener.com/kurs/aktie/ALTIMMUNE-INC-46246544/news/Altimmune-Inc-erhalt-von-der-FDA-die-Fast-Track-Zulassung-fur-Pemvidutid-zur-Behandlung-der-nich-45163880/?utm_source=telegram&utm_medium=social&utm_campaign=share